SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
52201 294 13 IMMU
Emcee:  idahoranch1 Type:  Moderated
Welcome to the troll-free, moderated message board for Immunomedics (IMMU).

IMMU is in a very exciting phase, one that promises real benefits for patients.

As far as the company is concerned:
- the new management (aka Gold for the proxy ballot color) is delivering on the stated plan
- the BLA for TNBC has been accepted by the FDA, target action date is January 18, 2019.
- there are other possible indications for Sacituzumab Govitecan (IMMU-132).
- the share price has enjoyed a very nice run-up since January 2017
- for the first time in a long time there's quite a bit of cash in the bank
- IMMU is building out staff, the expectation is that sales cycles start in late 2018/early 2019.

The above doesn't include other drug candidates, possible partnerships and the like. With the above in mind, here are links to a few posts, resources, and sites you might want to peruse:

- IMMU's status:
-- Company website:
-- News release about BLA for TNBC being accepted:
-- Staff build-out:
-- Company goal (stand-alone biopharma): Msg # 46214
-- Other irons in the fire besides TNBC: Msg # 45237
-- BLA approval timeline is Q1, 2019.

- Thoughts on this year's ASCO presentation (June 3, 2018):
-- Msg # 45911
-- Msg # 45929

- Buyout rumors and why they're almost, but not quite totally, a waste of electrons: Msg # 46157

Etiquette:

This board is moderated, meaning the moderator (me) can stop people from posting here if they violate our norms. What are "our norms"? Well, be adult, play nice about sums it up. There are three responses I encourage for keeping the discussion civil and useful when you encounter a post that annoys you. In order of preference:

1> report a ToU violation to the SI admins via the link at the bottom of each post, they're good at dealing with problems.

2> send the person who posted a private message and work it out. Privately.

3> send me a private message. Wait a couple of days before doing so please, I'll usually see the message in that time frame and act (or not).

4> stay focused on IMMU and leave politics out of it, even by inference. There are numerous forums you can spend as much time expounding on your favorite "why (insert favorite hot-button) is evil", we don't need to reiterate all that here.

5> do not engage in discussions about poster's motivations, etc. First of all, it's unprovable. Second I'd rather not wade through the inevitable pointless back-and-forth over something that'll never be settled anyway.

This board provides a forum for honest, civilized and friendly conversation. It is not a vehicle for spam or hidden agendas. New posters are not only welcome but are an important way to bring additional information and insights to the board. Over the years new posters have been welcomed into the group and have helped make the board successful. However, if you’re a new poster it is especially important to be sure that material assertions, be they pro or con, are thoughtful and supportable. While all posters must abide by the TOU, leeway can and will be granted to long-time posters who have made substantive contributions to the board and whose credibility has been established.



Please consider becoming a paid member. The SI admins do a very good job at keeping this board useful/fun. If you derive value from this forum, then SI deserves your support!

Finally, we all have internet connections and the like, please just skip all the breathless "It's up/down $X.Y in the first hour!" posts. Short-term price moves are generally noise anyway absent major news so we can wait until the evening to discuss price moves if we discuss them at all.

Again, welcome! I think you'll find this a place to learn about and contribute to others' understanding of IMMU and its prospects.

Best,
Erick
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52201I stand corrected. Been communicating with DiaperDaddy and it seems Mini Orals ajargonweary27 hours ago
52200Minnie Pearl?duwhee-8 hours ago
52199Wasn’t Mini Orals a country and western singer?jargonweary2yesterday
52198I thought both presentations were Mini Orals.sysiphus-yesterday
52197Translate in English, please.bobbseytwins20011Saturday
52196competitor adc The presentation was accepted as a minioral presentation. Howeverwinners182last Friday
52195John, >Still 4/4 is jaw dropping, especially measured against the increasingpatlawche11-last Friday
52194Hmmm, administrative error is pretty thin. The other Daiichi compound, U3-1402,JohnBeach4last Friday
52193Link to article on N of 1 trials, not only for already approved drugs, but futurkdd9991last Friday
52192Speculation - stock was already down 2 percent that day and news not as good as ladyPI1last Friday
52191"They are not shy about hiring!" They weren't last time either. Ierickerickson5last Friday
52190They are not shy about hiring! Lots of activity. Interesting too the IT intereJJINV3last Friday
52189JB or anyone, care to share baseless speculation or conspiracy on why it is not KeeptheFaith-last Thursday
52188Let's acknowledge....you did write *TOKE* Final toke from the ether signalsCelebrityEquity1last Thursday
52187Hat, We take your contrast as a true compliment. Wish we were him.bobbseytwins20013last Thursday
52186To stem the tide by drawing from the ether circuits, the Daiichi data to me is aTinfoilHat10last Thursday
52185I'm just glad the G's are not attending on the IMMU dime. They'd basduwhee1last Thursday
52184Late breaking abstract deadline was july 19. Daiichi said during their last earJohnBeach2last Wednesday
52183Even so the abstract deadline was April 10th. I would imagine there would be no mrc7581last Wednesday
52182Right but when you go to the World Lung conference website and find presentationJohnBeach-last Wednesday
52181Here is the link on Daiichi Sankyo releasing their data. prnewswire.comEagleRare-last Wednesday
52180World Lung website says full abstracts release today at 5 pm ET. According to tJohnBeach1last Wednesday
52179I think the last two days are likely the CRL SRPT got from FDA. It was unexpecteidahoranch12last Wednesday
52178I was thinking the recent sell off this week was due to updated 1062 info today.Longtimeinvestor-last Wednesday
52177Sept 7th - 9th. Well that was a big ball of nothing, LOL.idahoranch11last Wednesday
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):